1-Ethoxy-2-Butoxybenzene

1-Ethoxy-2-Butoxybenzene

SCHEMBL3460023

CCCCOc1ccccc1OCC

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 9/20 0.66
CYP1A2 P05177 3/20 0.64
CYP2C19 P33261 3/20 0.64
CYP2C9 P11712 2/20 0.64
TDP1 Q9NUW8 2/20 0.63
CYP2D6 P10635 1/20 0.63
MAPT P10636 4/20 0.62
NPSR1 Q6W5P4 1/20 0.62
ALDH1A1 P00352 3/20 0.56
RAB9A P51151 1/20 0.54
ATM Q13315 1/20 0.54
HPGD P15428 1/20 0.54
GLA P06280 1/20 0.52
HTR1A P08908 1/20 0.51
ADRA1D P25100 1/20 0.51
ADRA1A P35348 1/20 0.51
ADRA1B P35368 1/20 0.51
KDM4E B2RXH2 1/20 0.50
TSHR P16473 1/20 0.50
LTA4H P09960 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1-Ethoxy-2-Pentoxybenzene SCHEMBL1276813 0.93 L3MBTL1 (0.69) L3MBTL1CYP1A2CYP2C19CYP2C9TDP1
1,2-Dibutoxybenzene SCHEMBL1226749 0.93 CYP1A2 (0.72) L3MBTL1CYP1A2CYP2C19CYP2C9TDP1
1,2-Dibutoxybenzene SCHEMBL29428927 0.93 CYP1A2 (0.72) L3MBTL1CYP1A2CYP2C19CYP2C9TDP1
SCHEMBL7636542 0.91 L3MBTL1 (0.67) L3MBTL1CYP1A2CYP2C19CYP2C9TDP1
SCHEMBL28515930 0.91 L3MBTL1 (0.67) L3MBTL1CYP1A2CYP2C19CYP2C9TDP1
SCHEMBL3081241 0.91 L3MBTL1 (0.67) L3MBTL1CYP1A2CYP2C19CYP2C9TDP1
SCHEMBL7639583 0.91 L3MBTL1 (0.67) L3MBTL1CYP1A2CYP2C19CYP2C9TDP1
1,2-Dibutoxybenzene SCHEMBL6236324 0.91 CYP1A2 (0.69) L3MBTL1CYP1A2CYP2C19CYP2C9TDP1
1-Ethoxy-2-Propoxybenzene SCHEMBL2919156 0.88 L3MBTL1 (0.64) L3MBTL1CYP1A2CYP2C19CYP2C9TDP1
1-Propoxy-2-Butoxybenzene SCHEMBL2846696 0.88 CYP1A2 (0.67) L3MBTL1CYP1A2CYP2C19CYP2C9TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399837-B1 POLYMERIZATION CATALYST FOR OLEFINS UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION 2002-06-04 US claimed
EP-1761570-B1 METHOD FOR IDENTIFYING ZIEGLER-NATTA COCATALYSTS DOW GLOBAL TECHNOLOGIES LLC (US) 2014-06-11 EP disclosed
US-20100190865-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, Lymanria dispar SIMON FRASER UNIVERSITY (CA) 2010-07-29 US disclosed
US-7683003-B2 Method for identifying Ziegler-Natta cocatalysts DOW GLOBAL TECHNOLOGIES, INC. (US) 2010-03-23 US disclosed
EP-1765489-B1 APPARATUS AND METHOD FOR ZIEGLER-NATTA RESEARCH DOW GLOBAL TECHNOLOGIES INC (US) 2009-11-11 EP disclosed
US-20070276102-A1 Method for Identifying Ziegler-Natta Cocatalysts DOW GLOBAL TECHNOLOGIES INC. 2007-11-29 US disclosed
US-20070224641-A1 Apparatus and method for ziegler-natta research CAMPBELL RICHARD E 2007-09-27 US disclosed
EP-1765489-A1 APPARATUS AND METHOD FOR ZIEGLER-NATTA RESEARCH Dow Gloval Technologies Inc. (US) 2007-03-28 EP disclosed
EP-1761570-A1 METHOD FOR IDENTIFYING ZIEGLER-NATTA COCATALYSTS Dow Gloval Technologies Inc. (US) 2007-03-14 EP disclosed
WO-2006043985-A1 METHOD FOR IDENTIFYING ZIEGLER-NATTA COCATALYST DOW GLOBAL TECHNOLOGIES INC. (US) 2006-04-27 WO disclosed
WO-2006007093-A1 APPARATUS AND METHOD FOR ZIEGLER-NATTA RESEARCH DOW GLOBAL TECHNOLOGIES INC. (US) 2006-01-19 WO disclosed
US-6399837-B1 POLYMERIZATION CATALYST FOR OLEFINS UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION 2002-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190865-A1 METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, Lymanria dispar L3MBTL3, L3MBTL4, L3MBTL1 L3MBTL1 3/4885CYP1A2 2220/4885CYP2C19 3786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.